Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1274, pseudogene (RNU6-1274P) is a non-protein-coding pseudogene derived from the U6 small nuclear RNA gene family, specifically designated as the 1274th annotated member in the human genome. U6 snRNAs are essential core components of the spliceosome, playing key roles in pre-mRNA splicing; however, as a pseudogene, RNU6-1274P is not functional—meaning it does not produce a functional U6 snRNA molecule. Pseudogenes like RNU6-1274P often arise from the retrotransposition or duplication of functional snRNA genes and accumulate mutations that prevent normal function. While some pseudogenes have been shown to act as regulatory RNAs (for example, by acting as decoys for microRNAs or affecting parental gene expression), there is no experimental evidence that RNU6-1274P has such roles. It is not a therapeutic or pharmacological target, does not encode for a protein or canonical RNA involved in cellular processes, and is not directly implicated in disease. The designation is correct and follows the established naming convention for pseudogenes of U6 small nuclear RNA [2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1274, pseudogene (RNU6-1274P).